Clinical Trial Update: Evaluation of Intravenous Sodium Valproate on Interleukin-6 Levels in Patients With TMJ Disc Displacement [Phase 2]

View source ↗

Summary

Phase 2 clinical trial from Tanta University evaluating intravenous sodium valproate to modulate interleukin-6 levels in temporomandibular joint internal derang…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Joint Disorders
• Temporomandibular Joint Internal Derangement

Drugs mentioned

• Sodium valproate (valproate)

Snippet

Sponsor: Tanta University | Conditions: Temporomandibular Joint Internal Derangement (ADWR) | Phase 2 | Status: ACTIVE_NOT_RECRUITING